Efficacy of Reinforcing Standard Therapy in COVID-19 Patients With Repeated Transfusion of Convalescent Plasma

NCT04803370 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

55

Enrollment

OTHER

Sponsor class

Conditions

Covid19

Interventions

OTHER: Convalescent Plasma with antibody against SARS-CoV-2.
OTHER: Standard treatment for COVID-19

Sponsor

Hospital Son Llatzer

Collaborators

[object Object]